Content
75%Weight 40%Scale 1-5Reviews the quality of instructions and guidance provided to agents. Good implementation is clear, handles edge cases, and produces reliable results.
A well-structured, actionable skill body with a clear phased workflow, concrete tool parameters, and useful fallback loops. Main gaps are example executability (pseudocode calls vs. runnable Python) and modest over-explanation of domain basics.
Suggestions
Make at least one example workflow a fully executable Python/Bash snippet (with imports and actual tool calls) to honor the 'COMPUTE, DON'T DESCRIBE' directive and lift actionability.
Trim the histone-mark glossary in the reasoning section to just the interpretation-relevant signal (active vs poised vs silenced) since Claude already knows the marks.
Consider moving the per-phase tool reference (Phases 1-4) into a separate references file, leaving SKILL.md as a tighter overview, to improve progressive disclosure.
| Dimension | Reasoning | Score |
|---|---|---|
Conciseness | Mostly lean and assumes domain competence, but a few interpretive glosses (e.g., enumerating which histone mark means what) edge slightly past what a genomics-aware model needs. | 4 / 5 |
Actionability | Concrete tool names with exact parameter names and gotchas ('variant_id, not rsid', 'assay_title="TF ChIP-seq"') and step-by-step example workflows, but examples are call pseudocode rather than the fully executable copy-paste Python the 'COMPUTE, DON'T DESCRIBE' header implies. | 4 / 5 |
Workflow Clarity | A clear seven-phase sequence with a flow diagram and a Fallback Strategies section providing error-recovery feedback loops; this is read-only analysis so the destructive-validation cap does not apply, but there is no formal per-phase validation checklist. | 4 / 5 |
Progressive Disclosure | Well-organized into clear sections with no bundle files present; the per-phase tool reference is inlined where a separate reference file could carry the bulk, a minor organization gap keeping it just below a top score. | 4 / 5 |
Total | 16 / 20 Passed |